The retail group returned to take part in a series B round that will find the expansion of chickpea-based protein developer InnovoPro's production capacity.
Israel-based protein product developer InnovoPro has received $15m in series B funding from investors including retail group Migros.
Venture capital firm Jerusalem Venture Partners led the round, which also featured CPT Capital, the alternative protein-focused VC fund representing the family office of Jeremy Coller, chairman of private equity firm Coller Capital.
InnovoPro has created a protein substitute made from non-genetically modified chickpeas for use in vegan products such as mayonnaise, ice cream, energy bars or veggie burgers.
The capital will…
